Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
3-Week Radiation Therapy As Effective As 5 Weeks For Early-Stage Breast Cancer
http://www.medicalnewstoday.com/articles/122616.php
Early-stage breast cancer patients who receive a more intensive course of radiation to their whole breast over three weeks is as effective as the standard, less intensive five-week whole breast radiation and offers patients more convenience at a lower cost, thereby providing a better quality of life, according to a randomized, long-term study presented September 22, 2008, in the plenary session at the American Society for Therapeutic Radiology and Oncology's 50th Annual Meeting in Boston.
1-Week Radiation Effective Breast Cancer Treatment
http://www.medicalnewstoday.com/articles/122614.php
Accelerated partial breast irradiation (APBI) using a type of radiation seed implants called balloon brachytherapy, a newer type of radiation treatment that offers more convenience to early-stage breast cancer patients by shortening radiation therapy from the standard six to seven weeks of treatment to only one week, is as effective in keeping breast cancer from coming back as the standard external beam radiation treatment, according to a study presented at the American Society for Therapeutic Radiology and Oncology's 50th Annual Meeting in Boston.
Side Effects Of Breast Cancer Treatment Reduced By Acupuncture
http://www.medicalnewstoday.com/articles/122612.php
Acupuncture is as effective and longer-lasting in managing the common debilitating side effects of hot flashes, night sweats, and excessive sweating (vasomotor symptoms) associated with breast cancer treatment and has no treatment side effects compared to conventional drug therapy, according to a first-of-its-kind study presented September 24, 2008, at the American Society for Therapeutic Radiology and Oncology's 50th Annual Meeting in Boston.
SAVI Device For Treatment Of Breast Cancer Shows Excellent Cosmetic Results, Few Side Effects
http://www.medicalnewstoday.com/articles/122589.php
A new study of breast cancer radiation treatment performed at 21st Century Oncology has found that the SAVI™ applicator delivered excellent cosmetic results with minimal side effects, for women who had not qualified for breast conservation therapy using a previously available balloon device.
Nipple Sparing Mastectomy With Reconstruction Surgery For Breast Cancer
http://www.medicalnewstoday.com/articles/122536.php
On Tuesday, October 7, watch surgeons from University Hospitals Case Medical Center perform a nipple sparing mastectomy with complete reconstruction. This breast-preserving procedure provides patients undergoing mastectomy with an excellent cosmetic outcome.
Breast Cancer Survivors Have High Quality Of Life Up To 15 Years After Lumpectomy/Radiation
http://www.medicalnewstoday.com/articles/122450.php
Women with breast cancer who are treated with lumpectomy and radiation report a high level of overall quality of life several years after treatment that is comparable to a general sampling of the adult women U.
Some Breast Cancer Patients Facing Radiation After A Mastectomy May Be Over-Treated
http://www.medicalnewstoday.com/articles/122448.php
A new study suggests standard radiation therapy for some breast cancer patients may not be medically required and may, therefore, be causing unnecessary serious side effects such as lymphedema and pulmonary problems.
New Computer-Based Tools Will Help Make Best Use Of Genetic Breast Cancer Tests
http://www.medicalnewstoday.com/articles/122445.php
A new federal project, funded by the Agency for Healthcare Research and Quality, will lead efforts to develop, implement and evaluate four computer-based decision-support tools that will help clinicians and patients better use genetic tests to evaluate and treat breast cancer.
Shorter Radiation Therapy Just As Effective For Early Stage Breast Cancer
http://www.medicalnewstoday.com/articles/122443.php
A shorter more intensive course of radiation therapy that lasts three weeks as opposed to the standard five appears to be just as effective for treating early stage breast cancer said researchers at a conference in Boston on Monday.
Breast MRI Scan Could Determine Need For Radiation Therapy
http://www.medicalnewstoday.com/articles/122432.php
For women whose breast cancer has spread to their lymph nodes, a magnetic resonance imaging (MRI) scan could replace exploratory surgery as the method for determining whether those women need radiation therapy to treat their disease, according to a study to be presented during the annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) which opens in Boston.
----------------------------------------------
** CANCER / ONCOLOGY News **
AVEO Pharmaceuticals Initiates First Clinical Trial Of Novel HGF Antagonist In Patients With Advanced Solid Tumors And Lymphomas
http://www.medicalnewstoday.com/articles/122627.php
AVEO Pharmaceuticals, Inc., announced that it has initiated a Phase 1 clinical trial to evaluate the safety, tolerability and recommended dose of SCH900105 (AV-299), its novel, highly potent antibody to hepatocyte growth factor (HGF), administered intravenously in patients with relapsed or refractory solid tumors or lymphoma.
Ikonisys Introduces Rare-Cell Test Designed To Determine Early Progression To Cervical Cancer
http://www.medicalnewstoday.com/articles/122625.php
Ikonisys, a leading provider of next-generation, cell-based diagnostic solutions, announced today the launch of its clinically-validated, novel cervical cancer test, <i>onco</i>FISH® cervical.
Cancer Patients Experience Increased Risk Of Learning And Memory Problems
http://www.medicalnewstoday.com/articles/122617.php
Cancer patients with tumors that have spread to the brain (brain metastases) who undergo stereotactic radiosurgery (SRS) and whole brain radiation have more than double the risk of developing learning and memory problems, compared to those who only have stereotactic radiosurgery, according to a randomized study presented at the American Society for Therapeutic Radiology and Oncology's 50th Annual Meeting in Boston.
Family History Of Brain Tumors Linked To Increased Risk Of Brain Cancer
http://www.medicalnewstoday.com/articles/122607.php
People with a family history of cancerous brain tumors appear to be at higher risk of developing the same kind of tumors compared to people with no such family history, according to a study published in the September 23, 2008, issue of <i>Neurology®</i>, the medical journal of the American Academy of Neurology.
Orexo: UK Marketing Approval Issued For Abstral For The Treatment Of Cancer Pain
http://www.medicalnewstoday.com/articles/122604.php
Orexo AB (STO:ORX) confirms the announcement made by ProStrakan Group plc (LSE:PSK), Orexo's partner for Abstral® in Europe and North America, that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Marketing Authorisation for Abstral (for breakthrough cancer pain).
Link Between Variant Of Vitamin D Receptor Gene And Melanoma Risk
http://www.medicalnewstoday.com/articles/122597.php
A new analysis indicates an association between a gene involved in vitamin D metabolism and skin cancer. Published in the November 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that individuals with certain variants in a vitamin D-related gene, called BsmI, may be at an increased risk of developing melanoma.
The Use Of Ultrasound In The Fight Against Cancer
http://www.medicalnewstoday.com/articles/122585.php
A revolutionary new ultrasonic treatment for liver and kidney cancer offers a surgery-free procedure for patients in the UK. Ultrasound is high frequency sound beyond the range of human hearing and has been employed in a variety of ways in the medical field including, in diagnostics to look inside the body and observe a growing foetus, in physiotherapy as a tool to aid the rejuvenation of muscles and pain control, and now, in the treatment of tumours.
Discovery Of New Drug Target For Inflammatory Disease By UC Davis Researchers
http://www.medicalnewstoday.com/articles/122557.php
UC Davis researchers have defined a cellular process that promotes inflammation and, at the same time, found an important starting point for identifying and testing new drugs for diseases such as sepsis, rheumatoid arthritis, cardiovascular disease and some cancers.
Scientists Discover Cancer-Causing Role Of Gene Proteins
http://www.medicalnewstoday.com/articles/122543.php
Dr. Tak Mak and scientists at The Campbell Family Institute for Breast Cancer Research at Princess Margaret Hospital have discovered the role of two "cousins" in the genetic family tree of cancer development.
Neighbors Unite To Help Young Leukemia Patient In Dire Need
http://www.medicalnewstoday.com/articles/122537.php
Neighbors, friends and family of 21-year-old leukemia patient, Bert Gasiewski, will be holding a marrow donor drive on Sunday, September 28th to recruit marrow donors who can potentially help save his life and the lives of other people diagnosed with life-threatening blood cancers.
Proton Therapy Lowers Chance Of Later Cancers
http://www.medicalnewstoday.com/articles/122532.php
Patients who are treated with proton therapy (a specialized type of external beam radiation therapy using protons rather than X-rays to treat cancer) decreases the risk of patients developing a secondary cancer by two-fold, compared to being treated with standard photon radiation treatment, according to a first-of-its-kind study presented September 22, 2008, at the American Society for Therapeutic Radiology and Oncology's 50th Annual Meeting in Boston.
Non-Drug Therapy For Chemotherapy-Related Nausea Gets The Go Ahead For Large UK Trial
http://www.medicalnewstoday.com/articles/122531.php
The largest trial worldwide to assess the use of Sea-Band© acupressure wrist bands* for chemotherapy-related nausea, will start next month (October). The first of its kind to run in the NHS, the study is funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme.
MSNBC.com Examines New Ovarian Tissue Transplant Procedure
http://www.medicalnewstoday.com/articles/122497.php
<BR /><A href="http://www.msnbc.msn.com/id/26772455/" target=_new>MSNBC.com</A> on Thursday examined an experimental procedure that aims to preserve the fertility of girls and young women undergoing medical treatments for cancer and other conditions that could cause them to become sterile.
UC Berkeley Bioengineer To Receive NIH New Innovator Award
http://www.medicalnewstoday.com/articles/122479.php
A University of California, Berkeley, researcher who studies cellular mechanics and biomaterials is the recipient of a National Institutes of Health (NIH) award honoring innovative new scientists.
Nanobiotix Announces Issue Of European Patent Protecting Its NanoXray™ Anticancer Platform
http://www.medicalnewstoday.com/articles/122478.php
Nanobiotix, an emerging nanomedicine company focused on cancer therapy, announced that the European Patent Office (EPO) has issued Patent No. 1744789 to the Company, related to its "novel activable particles that can be used in the health sector.
Doctors Ignore Most Opportunities To Express Empathy
http://www.medicalnewstoday.com/articles/122468.php
US researchers studying doctors and surgeons treating lung cancer patients found they missed most opportunities to respond empathically in consultations where their patients expressed worries and concerns about symptoms, treatment options and death.
Genmab Completes Recruitment Of Patients In The Phase II Study Of Ofatumumab In Combination With CHOP Chemotherapy
http://www.medicalnewstoday.com/articles/122465.php
Genmab A/S (OMX: GEN) announced it has completed recruitment of 56 previously untreated follicular non-Hodgkin's lymphoma (NHL) patients in the Phase II study of ofatumumab (HuMax-CD20(R)) in combination with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP).
Quality Assurance Programs Improve Clinical Trials
http://www.medicalnewstoday.com/articles/122452.php
Quality assurance programs like the one at the Quality Assurance Review Center (QARC) in Worcester, Mass., strengthen the quality of clinical trials, including cooperative groups conducting National Cancer Institute-supported clinical trials, thereby improving the standard of care in cancer patients, according to a study presented at the American Society for Therapeutic Radiology and Oncology's 50th Annual Meeting in Boston.
Pancreatic Cancer: New Options When An Old Enemy Returns
http://www.medicalnewstoday.com/articles/122446.php
Pancreatic cancer is one of the most challenging malignancies to treat, and recurrence is common, even after initial treatment with surgery and radiation. When the cancer does return, treatment options are often limited to chemotherapy, but researchers at Georgetown's Lombardi Comprehensive Cancer Center are utilizing the precision allowed by CyberKnife® to see if radiosurgery is a viable treatment option in select patients.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
Ikonisys Introduces Rare-Cell Test Designed To Determine Early Progression To Cervical Cancer
http://www.medicalnewstoday.com/articles/122625.php
Ikonisys, a leading provider of next-generation, cell-based diagnostic solutions, announced today the launch of its clinically-validated, novel cervical cancer test, <i>onco</i>FISH® cervical.
First Published Study Of New HPV Test For Developing Countries Shows High Accuracy In Predicting Cervical Disease
http://www.medicalnewstoday.com/articles/122431.php
A new HPV test developed by QIAGEN specifically for use in regions of the world with scarce resources is "substantially" more accurate in identifying women with cervical disease than the current methods (Pap testing and visual inspection) in these countries.
Helix Receives Approval To Open Sites In Germany For Its Ongoing Clinical Trial With Topical Interferon Alpha-2b In Patients With Ano-Genital Warts
http://www.medicalnewstoday.com/articles/122414.php
Helix BioPharma announced that it has received the necessary regulatory approvals to open clinical sites in Germany to expand upon its clinical trial with Topical Interferon Alpha-2b in patients with ano-genital warts, which is presently underway in Sweden.
----------------------------------------------
** COLORECTAL CANCER News **
Exposing Cancer-Causing Gut Bacteria
http://www.medicalnewstoday.com/articles/122626.php
Normal gut bacteria are thought to be involved in colon cancer but the exact mechanisms have remained unknown. Now, scientists from the USA have discovered that a molecule produced by a common gut bacterium activates signalling pathways that are associated with cancer cells.
American Journal Of Gastroenterology Publishes Study Of Advanced Noninvasive DNA Test For Colorectal Cancer
http://www.medicalnewstoday.com/articles/122608.php
EXACT Sciences Corporation (NASDAQ: EXAS) announced the publication in the <i>American Journal of Gastroenterology </i>the results of a multi-center study of EXACT's Version 2 technology for stool-based DNA screening for colorectal cancer.
Radiation Before Surgery Reduces Quality Of Life And Risk Of Recurrence For Rectal Cancer Patients
http://www.medicalnewstoday.com/articles/122517.php
The use of a short one week course of radiation before surgery for rectal cancer leads to a reduced risk of recurrence but with some impairment in quality of life for sexual and bowel function, according to an international study presented September 22, 2008, at the American Society for Therapeutic Radiology and Oncology's 50th Annual Meeting in Boston.
----------------------------------------------
** LUNG CANCER News **
Empathy Often Lacking In Physician Consultations
http://www.medicalnewstoday.com/articles/122595.php
In consultations with patients with lung cancer, physicians rarely responded empathically to the concerns of the patients about mortality, symptoms or treatment options, according to a study led by a University of Rochester Medical Center researcher.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
AVEO Pharmaceuticals Initiates First Clinical Trial Of Novel HGF Antagonist In Patients With Advanced Solid Tumors And Lymphomas
http://www.medicalnewstoday.com/articles/122627.php
AVEO Pharmaceuticals, Inc., announced that it has initiated a Phase 1 clinical trial to evaluate the safety, tolerability and recommended dose of SCH900105 (AV-299), its novel, highly potent antibody to hepatocyte growth factor (HGF), administered intravenously in patients with relapsed or refractory solid tumors or lymphoma.
Neighbors Unite To Help Young Leukemia Patient In Dire Need
http://www.medicalnewstoday.com/articles/122537.php
Neighbors, friends and family of 21-year-old leukemia patient, Bert Gasiewski, will be holding a marrow donor drive on Sunday, September 28th to recruit marrow donors who can potentially help save his life and the lives of other people diagnosed with life-threatening blood cancers.
Genmab Completes Recruitment Of Patients In The Phase II Study Of Ofatumumab In Combination With CHOP Chemotherapy
http://www.medicalnewstoday.com/articles/122465.php
Genmab A/S (OMX: GEN) announced it has completed recruitment of 56 previously untreated follicular non-Hodgkin's lymphoma (NHL) patients in the Phase II study of ofatumumab (HuMax-CD20(R)) in combination with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP).
Recruitment Completed In Ofatumumab NHL Front Line Study
http://www.medicalnewstoday.com/articles/122412.php
Genmab A/S (OMX: GEN) announced it has completed recruitment of 56 previously untreated follicular non-Hodgkin's lymphoma (NHL) patients in the Phase II study of ofatumumab (HuMax-CD20(R)) in combination with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP).
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Increased Survival For Men With Prostate Cancer By Adding Radiation To Hormone Therapy
http://www.medicalnewstoday.com/articles/122609.php
For men with locally advanced prostate cancer the addition of radiation treatment to anti-androgen hormone therapy reduces the risk of dying of prostate cancer by 50 percent compared to those who have anti-androgen hormone treatment alone, according to a randomized study presented at the American Society for Therapeutic Radiology and Oncology's 50th Annual Meeting in Boston.
Year Results Confirm Unique Long-Term Survival Benefits Of Adjuvant Goserelin (Zoladex) In Locally Advanced Prostate Cancer
http://www.medicalnewstoday.com/articles/122564.php
Goserelin, when used as adjuvant treatment with radiotherapy, improves 10-year overall survival as compared to radiotherapy alone in patients with locally advanced prostate cancer (when the cancer has spread into the capsule of the prostate or through the prostate into the surrounding tissues), according to results[i] presented for the first time at the American Society of Therapeutic Radiology and Oncology Congress.
Men With Health Risk Behaviors Unaware Of PSA Test
http://www.medicalnewstoday.com/articles/122538.php
New research of 7,297 men in California, published in The <a href="http://www.jurology.com" target="_blank" rel="nofollow"><i>Journal of Urology </i>®</a>, shows that self-reported prostate-specific antigen (PSA) test awareness was lower in current smokers, physically inactive men and obese men - a population with what researchers called, "health risk behaviors.
The Prostate Cancer Charity Announces First Ever Prostate Cancer Awareness Month
http://www.medicalnewstoday.com/articles/122510.php
The Prostate Cancer Charity is pleased to announce it is extending Prostate Cancer Awareness Week to a month long event. The inaugural Prostate Cancer Awareness Month will run in March 2009, with a four week programme of events, partnerships and awareness-raising activities.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment